Tag: Volixibat

Mirum Pharmaceuticals raises $120m to advance Maralixibat into phase 3

pharmanewsdaily- December 2, 2018

Mirum Pharmaceuticals, a clinical stage pharma company in San Diego, has raised $120 million in a Series A funding round to support the development of ... Read More